SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 484.10 |
Enterprise Value ($M) | 265.22 |
Book Value ($M) | 202.05 |
Book Value / Share | 2.48 |
Price / Book | 2.40 |
NCAV ($M) | 181.59 |
NCAV / Share | 2.23 |
Price / NCAV | 2.67 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.45 |
Return on Assets (ROA) | -0.72 |
Return on Equity (ROE) | -0.96 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.92 |
Current Ratio | 5.92 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 247.69 |
Assets | 268.14 |
Liabilities | 66.10 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -93.87 |
Net Income | -95.73 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -64.36 |
Cash from Investing | 0.00 |
Cash from Financing | 21.85 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Commodore Capital Lp | 8.30 | ||
13G | Deep Track Capital, LP | 9.49 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
81,683 | 484,979 | 16.84 | |
86,748 | 403,394 | 21.50 | |
146,418 | 825,534 | 17.74 | |
197,032 | 786,376 | 25.06 | |
(click for more detail) |
Similar Companies | |
---|---|
MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io